Jagsonpal Pharmaceuticals standalone net profit rises 9.69% in the September 2025 quarter

Sales decline 0.29% to Rs 74.47 crore

Net profit of Jagsonpal Pharmaceuticals rose 9.69% to Rs 12.57 crore in the quarter ended September 2025 as against Rs 11.46 crore during the previous quarter ended September 2024. Sales declined 0.29% to Rs 74.47 crore in the quarter ended September 2025 as against Rs 74.69 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	74.47	74.69	0
OPM %	22.08	21.81	-
PBDT	19.20	17.71	8
PBT	16.81	15.37	9
NP	12.57	11.46	10

Powered by Capital Market - Live News